MBX Biosciences, Inc. (MBX)
54.11
-0.05
(-0.09%)
USD |
NASDAQ |
Oct 29, 16:00
54.11
0.00 (0.00%)
After-Hours: 16:23
MBX Biosciences Market Cap : 2.595B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 2.597B |
| October 27, 2026 | 2.540B |
| October 26, 2026 | 2.411B |
| October 23, 2026 | 2.326B |
| October 22, 2026 | 2.420B |
| October 21, 2026 | 2.586B |
| October 20, 2026 | 2.565B |
| October 19, 2026 | 2.516B |
| October 16, 2026 | 2.379B |
| October 15, 2026 | 2.432B |
| October 14, 2026 | 2.341B |
| October 13, 2026 | 2.350B |
| October 12, 2026 | 2.494B |
| October 09, 2026 | 2.553B |
| October 08, 2026 | 2.553B |
| October 07, 2026 | 2.615B |
| October 06, 2026 | 2.729B |
| October 05, 2026 | 2.807B |
| October 02, 2026 | 2.806B |
| October 01, 2026 | 2.712B |
| September 30, 2026 | 2.811B |
| September 29, 2026 | 2.769B |
| September 28, 2026 | 2.759B |
| September 25, 2026 | 2.572B |
| September 24, 2026 | 2.656B |
| Date | Value |
|---|---|
| September 23, 2026 | 2.776B |
| September 22, 2026 | 2.972B |
| September 21, 2026 | 2.922B |
| September 18, 2026 | 3.017B |
| September 17, 2026 | 3.064B |
| September 16, 2026 | 2.952B |
| September 15, 2026 | 2.929B |
| September 14, 2026 | 2.853B |
| September 11, 2026 | 2.830B |
| September 10, 2026 | 2.922B |
| September 09, 2026 | 3.017B |
| September 08, 2026 | 3.020B |
| September 04, 2026 | 2.959B |
| September 03, 2026 | 2.945B |
| September 02, 2026 | 2.920B |
| September 01, 2026 | 2.922B |
| August 31, 2026 | 2.954B |
| August 28, 2026 | 3.021B |
| August 27, 2026 | 3.183B |
| August 26, 2026 | 3.201B |
| August 25, 2026 | 3.290B |
| August 24, 2026 | 3.183B |
| August 21, 2026 | 3.181B |
| August 20, 2026 | 3.181B |
| August 19, 2026 | 3.280B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.679B |
| Corcept Therapeutics, Inc. | 9.298B |
| Veru, Inc. | 37.85M |
| Johnson & Johnson | 662.37B |
| Eli Lilly & Co. | 1.294T |
Market Cap Related Metrics
| PEG Ratio | -5.117 |
| Price to Book Value | 6.335 |
| Price | 54.11 |
| Earnings Yield | -4.45% |
| PEGY Ratio | -5.117 |